Extracellular matrix heterogeneity regulates three-dimensional morphologies of breast adenocarcinoma cell invasion

Advanced Healthcare Materials

Volumn 2, Issue 6, 2013, Pages 790-794

  Shin, Yoojin ^a   Kim, Hyunju ^a   Han, Sewoon ^a   Won, Jihee ^a   Jeong, Hyo Eun ^a   Lee, Eun Sook ^b   Kamm, Roger D ^c   Kim, Jae Hong ^a   Chung, Seok ^a  

^a Korea University   (South Korea)

^b National Cancer Center   (South Korea)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cancer metastasis; Extracellular matrices; Hydrogels; Microfluidics

Indexed keywords

HYDROGELS; MATERIALS; MICROFLUIDICS;

ADENOCARCINOMA CELLS; CANCER METASTASIS; EXTRACELLULAR MATRICES; THREE DIMENSIONAL MORPHOLOGY;

DISEASES;

ARTICLE; BASEMENT MEMBRANE; BREAST ADENOCARCINOMA; BREAST METASTASIS; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL CULTURE; CELL HETEROGENEITY; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; COCULTURE; EXTRACELLULAR MATRIX; HUMAN; MICROFLUIDIC ANALYSIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; STROMA CELL; THREE DIMENSIONAL IMAGING; TUMOR MICROENVIRONMENT;

EID: 84879608414     PISSN: 21922640     EISSN: 21922659     Source Type: Journal    
DOI: 10.1002/adhm.201200320     Document Type: Article

References (26)

1. I. J. Fidler, Nat. Rev. Cancer 2003, 3, 453.
2. P. Friedl, S. Alexander, Cell 2011, 147, 992.
3. P. Friedl, Curr. Opin. Cell Biol. 2004, 16, 14.
4. K. Wolf, P. Friedl, Trends Cell Biol. 2011, 21, 736.
5. S. Bhatia, J. V. Frangioni, R. M. Hoffman, A. J. Iafrate, K. Polyak, Nat. Biotechnol. 2012, 30, 604.
6. R. G. Rowe, S. J. Weiss, Annu. Rev. Cell Dev. Biol. 2009, 25, 567.
7. K. L. Sodek, T. J. Brown, M. J. Ringuette, BMC Cancer 2008, 8.
8. V. S. LeBleu, B. MacDonald, R. Kalluri, Exp. Biol. Med. 2007, 232, 1121.
9. a) L. Ma, J. Teruya-Feldstein, R. A. Weinberg, Nature 2007, 449, 682; b) H. K. Kleinman, G. R. Martin, Semin. Cancer Biol., 2005, 15, 378.
10. K. B. Hotary, E. D. Allen, P. C. Brooks, N. S. Datta, M. W. Long, S. J. Weiss, Cell 2003, 114, 33.
11. D. Radisky, J. Muschler, M. Bissell, Cancer Invest. 2002, 20, 139.
12. K. Mi, G. Wang, Z. Liu, Z. Feng, B. Huang, X. Zhao, Macromol. Biosci. 2009, 9, 437.
13. K. Wolf, I. Mazo, H. Leung, K. Engelke, U. H. von Andrian, E. I. Deryugina, A. Y. Strongin, E. B. Brocker, P. Friedl, J. Cell Biol. 2003, 160, 267.
14. Z. N. Demou, M. Awad, T. McKee, J. Y. Perentes, X. Wang, L. L. Munn, R. K. Jain, Y. Boucher, Cancer Res. 2005, 65, 5674.
15. R. E. Hurst, K. D. Kyker, R. B. Bonner, R. D. Bowditch, G. P. Hemstreet, 3rd, Anticancer Res. 2003, 23, 3119.
16. M. G. Dozmorov, K. D. Kyker, R. Saban, N. Knowlton, I. Dozmorov, M. B. Centola, R. E. Hurst, BMC Cancer 2006, 6, 12.
17. M. A. Wozniak, P. J. Keely, Biol. Proced. Online 2005, 7, 144.
18. S. Chung, R. Sudo, V. Vickerman, I. Zervantonakis, R. Kamm, Ann. Biomed. Eng. 2010, 38, 1164.
19. S. Chung, R. Sudo, P. Mack, C. Wan, V. Vickerman, R. Kamm, Lab Chip 2009, 9, 269
20. S. Chung, R. Sudo, I. Zervantonakis, T. Rimchala, R. Kamm, Adv. Mater. 2009, 21, 4863
21. R. Sudo, S. Chung, I. Zervantonakis, V. Vickerman, Y. Toshimitsu, L. Griffith, R. Kamm, FASEB J. 2009, 23, 2155.
22. Y. Yamasaki, K. Sumimoto, M. Nishikawa, F. Yamashita, K. Yamaoka, M. Hashida, Y. Takakura, J. Pharmacol. Exp. Ther. 2002, 301, 467.
23. G. S. Jeong, S. Han, Y. Shin, G. H. Kwon, R. D. Kamm, S.-H. Lee, S. Chung, Anal. Chem. 2011, 83, 8454.
24. Y. H. Hsiao, M. C. Chou, C. Fowler, J. T. Mason, Y. Man, J. Cancer 2010, 1, 6.
25. A. F. Chambers, L. M. Matrisian, J. Natl. Cancer Inst. 1997, 89, 1260.
26. M. Egeblad, Z. Werb, Nat. Rev. Cancer 2002, 2, 161.